Implementation and Quality Control of Lung Cancer EGFR Genetic Testing by MALDI- TOF Mass Spectrometry in Taiwan Clinical Practice

التفاصيل البيبلوغرافية
العنوان: Implementation and Quality Control of Lung Cancer EGFR Genetic Testing by MALDI- TOF Mass Spectrometry in Taiwan Clinical Practice
المؤلفون: Su, Kang-Yi, Kao, Jau-Tsuen, Ho, Bing-Ching, Chen, Hsuan-Yu, Chang, Gee-Cheng, Ho, Chao-Chi, Yu, Sung-Liang, 何炳慶, 俞松良, 蘇剛毅, 高照村, 何肇基
المساهمون: 臺大醫院-內科部, 臺大醫院-檢驗醫學部, 臺大醫學院, 臺大醫學院-光電生物醫學研究中心, 臺大醫學院-病理學科暨研究所, 臺大醫學院-醫學檢驗暨生物技術學系暨研究所, Su, Kang-Yi, Kao, Jau-Tsuen, Ho, Bing-Ching, Chen, Hsuan-Yu, Chang, Gee-Cheng, Ho, Chao-Chi, Yu, Sung-Liang, 何炳慶, 俞松良, 蘇剛毅, 高照村, 何肇基
سنة النشر: 2016
المجموعة: National Taiwan University Institutional Repository (NTUR)
الوقت: 136
الوصف: Molecular diagnostics in cancer pharmacogenomics is indispensable for making targeted therapy decisions especially in lung cancer. For routine clinical practice, the flexible testing platform and implemented quality system are important for failure rate and turnaround time (TAT) reduction. We established and validated the multiplex EGFR testing by MALDI-TOF MS according to ISO15189 regulation and CLIA recommendation in Taiwan. Totally 8,147 cases from Aug-2011 to Jul-2015 were assayed and statistical characteristics were reported. The intra-run precision of EGFR mutation frequency was CV 2.15% (L858R) and 2.77% (T790M); the inter-run precision was CV 3.50% (L858R) and 2.84% (T790M). Accuracy tests by consensus reference biomaterials showed 100% consistence with datasheet (public database). Both analytical sensitivity and specificity were 100% while taking Sanger sequencing as the gold-standard method for comparison. EGFR mutation frequency of peripheral blood mononuclear cell for reference range determination was 0.002 +/- 0.016% (95% CI: 0.000-0.036) (L858R) and 0.292 +/- 0.289% (95% CI: 0.000-0.871) (T790M). The average TAT was 4.5 working days and the failure rate was less than 0.1%. In conclusion, this study provides a comprehensive report of lung cancer EGFR mutation detection from platform establishment, method validation to clinical routine practice. It may be a reference model for molecular diagnostics in cancer pharmacogenomics. ; 病理學科暨研究所 ; 醫學院 ; 期刊論文
نوع الوثيقة: other/unknown material
اللغة: English
العلاقة: Sci Rep, 6; http://ntur.lib.ntu.edu.tw/handle/246246/278763Test
DOI: 10.1038/srep30944
الإتاحة: https://doi.org/10.1038/srep30944Test
http://ntur.lib.ntu.edu.tw/handle/246246/278763Test
رقم الانضمام: edsbas.2F746147
قاعدة البيانات: BASE